Phase 1 N=46 CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies
Advanced Non-Hematologic Malignancies
Primary: Maximum Tolerated Dose (MTD) — NA mg/kg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=21 The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life
Dementia
Primary: Reaction Time for Simple Reaction Time Test at Baseline, Week 8, and Week 24 — 1024.06; 729.18; 466.60; 671.33 milliseconds
Phase 4 N=251 Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients
Angina Pectoris
Primary: The Impact on 24-hr Average Heart Rate Between Two Groups (Betaloc ZOK® 95mg vs. 190mg) — 71.4; 70.9; 70.9; 68.6 Bpm
N/A N=40 Desflurane Versus Propofol in the Sitting Position
Cerebral Ischemia
Primary: Regional Cerebral Oxygen Satuation (rSO2) — 77.4; 72.5; 76; 70 percentage of rSO2 (%)
N/A N=719 Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)
Type 2 Diabetes Mellitus
Primary: Number of Participants Experiencing Hypoglycemic Episodes in the 6 Months Prior to Enrollment — 305 Participants
Phase 4 N=190 An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
Cancer Pain
Primary: Percentage of Treatment Response in Sleep Disturbance Caused by Cancer Pain — 34.9 Percentage of treatment response
Phase 4 N=13 Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis
Chronic Uveitis
Primary: Effects of Infliximab on Uveitis Disease Activity. — 3; 6 participants
Phase 3 N=347 Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
Asthma
Primary: Change From Baseline in Weighted-mean 24-hour Serial Forced Expiratory Volume in One Second (FEV1) at Week 12 — 0.289; 0.359; 0.283 Liters — p=0.244
Phase 2 N=42 Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma
Lymphoma
Primary: Progression-free Survival — 18 participants
Phase 4 N=1,059 An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back Pain
Low Back Pain · Shoulder Pain · Neck Pain
Primary: Pain Intensity Score Based on Numeric Rating Scale (NRS) at Hour 0.5 — 5.29 Units on a scale
Phase 2 N=35 A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection
Hepatitis C
Primary: Change From Baseline in Plasma Log10 Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) at Week 4 - Full Analysis Set — 6.38843; 6.67823; 6.66254; 6.42047 log10 IU/mL…
Phase 3 N=55 A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model
Dental Caries
Primary: Percentage Surface Microhardness Recovery of Test Dentifrices Relative to Placebo Dentifrice — 30.72; 29.49; 28.29; 25.13 %SMHR — p=<0.0001
N/A N=9 Aprepitant Effects on Oxycodone Response
Narcotic Abuse
Primary: Abuse Liability Proxy — 0.197; 0.483; 0.159; 7.678 units on a scale (points 0-100) — p=<.05
Phase 3 N=261 Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes · High Blood Sugar
Primary: Adjusted Mean Change in HbA1c Levels — -0.41; -0.45; -0.06 Percent — p=<0.0001
Phase 1 N=12 ORAL T-8 Oral Testosterone for Male Hormonal Contraception
Healthy
Primary: Maximum Testosterone Concentration — 924; 741 ng/dL — p=0.05